Evercore ISI Starts Prelude Therapeutics (PRLD) at Outperform

September 18, 2026 6:42 AM EDT Send to a Friend
Evercore ISI analyst Gavin Clark-Gartner initiates coverage on Prelude Therapeutics ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login